Chronic myeloid leukaemia and Gastrointestinal inflammation


Gastrointestinal inflammation is found among people with Chronic myeloid leukaemia, especially for people who are female, 60+ old.

The study analyzes which people have Gastrointestinal inflammation with Chronic myeloid leukaemia. It is created by eHealthMe based on reports of 29 people who have Chronic myeloid leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 18, 2022

29 people who have Chronic Myeloid Leukaemia and Gastrointestinal Inflammation are studied.

What is Chronic myeloid leukaemia?

Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood) is found to be associated with 668 drugs and 395 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 774 drugs and 512 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Chronic myeloid leukaemia reports submitted per year:

Would you have Gastrointestinal inflammation when you have Chronic myeloid leukaemia?

Gender of people who have Chronic Myeloid Leukaemia and experienced Gastrointestinal Inflammation *:

  • female: 58.62 %
  • male: 41.38 %

Age of people who have Chronic Myeloid Leukaemia and experienced Gastrointestinal Inflammation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 27.78 %
  • 40-49: 11.11 %
  • 50-59: 5.5600000000000005 %
  • 60+: 55.56 %

Common co-existing conditions for these people *:

  1. Diabetes: 5 people, 17.24%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.90%
  3. High Blood Cholesterol: 2 people, 6.90%
  4. Gastric Disorder (disease of stomach): 2 people, 6.90%
  5. Pain: 1 person, 3.45%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 3.45%

Common drugs taken by these people *:

  1. Tasigna: 21 people, 72.41%
  2. Asa: 7 people, 24.14%
  3. Sertraline: 7 people, 24.14%
  4. Glivec: 6 people, 20.69%
  5. Pantoprazole: 4 people, 13.79%
  6. Sprycel: 3 people, 10.34%
  7. Zyrtec: 2 people, 6.90%
  8. Tricor: 2 people, 6.90%
  9. Coenzyme Q10: 2 people, 6.90%
  10. Fish Oil: 2 people, 6.90%

Common symptoms for these people *:

  1. Pain: 19 people, 65.52%
  2. Weakness: 15 people, 51.72%
  3. Diarrhea: 15 people, 51.72%
  4. Malaise (a feeling of general discomfort or uneasiness): 14 people, 48.28%
  5. Nausea (feeling of having an urge to vomit): 12 people, 41.38%
  6. Headache (pain in head): 11 people, 37.93%
  7. Rashes (redness): 11 people, 37.93%
  8. Weight Decreased: 10 people, 34.48%
  9. Sinusitis (inflammation of sinus): 10 people, 34.48%
  10. Stress And Anxiety: 10 people, 34.48%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study is based on Gastrointestinal inflammation and Chronic myeloid leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: